GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cizzle Biotechnology Holdings PLC (LSE:CIZ) » Definitions » Gross-Profit-to-Asset %

Cizzle Biotechnology Holdings (LSE:CIZ) Gross-Profit-to-Asset % : 0.00% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Cizzle Biotechnology Holdings Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Cizzle Biotechnology Holdings's annualized Gross Profit for the quarter that ended in Dec. 2023 was £0.00 Mil. Cizzle Biotechnology Holdings's average Total Assets over the quarter that ended in Dec. 2023 was £2.22 Mil. Therefore, Cizzle Biotechnology Holdings's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 0.00%.


Cizzle Biotechnology Holdings Gross-Profit-to-Asset % Historical Data

The historical data trend for Cizzle Biotechnology Holdings's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cizzle Biotechnology Holdings Gross-Profit-to-Asset % Chart

Cizzle Biotechnology Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Cizzle Biotechnology Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Cizzle Biotechnology Holdings's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Cizzle Biotechnology Holdings's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cizzle Biotechnology Holdings's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cizzle Biotechnology Holdings's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Cizzle Biotechnology Holdings's Gross-Profit-to-Asset % falls into.



Cizzle Biotechnology Holdings Gross-Profit-to-Asset % Calculation

Cizzle Biotechnology Holdings's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=0/( (2.785+1.693)/ 2 )
=0/2.239
=0.00 %

Cizzle Biotechnology Holdings's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=0/( (2.754+1.693)/ 2 )
=0/2.2235
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Cizzle Biotechnology Holdings Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Cizzle Biotechnology Holdings's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cizzle Biotechnology Holdings (LSE:CIZ) Business Description

Traded in Other Exchanges
N/A
Address
C/o SGH Secretaries Limited, 60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Cizzle Biotechnology Holdings PLC is in the early stages of developing a blood test for the early detection of a majority of the different forms of lung cancer. Its proof-of-concept prototype test is based on the ability to detect a stable plasma biomarker, a variant of C1Z1 known as CIZ1B. C1Z1 is a naturally occurring cell nuclear protein involved in DNA replication, and the targeted C1Z1B variant is highly correlated with early stage lung cancer.

Cizzle Biotechnology Holdings (LSE:CIZ) Headlines

No Headlines